Understanding opioids in veterinary medicine
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
EX-99.2
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Structure–activity relationship investigation of triazole-based kappa opioid receptor agonists | SpringerLink
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
Opioid Receptor | kappa, mu Opioid Receptor
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
The Impact of Opioid Analgesics and the Pharmacogenomics of ABCB1 in Opioid Dependence and Pharmacotherapies: A Short Review
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
κ-opioid receptor - Wikipedia
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Opioids in cancer: The κ‑opioid receptor (Review)
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Nanobody-enabled monitoring of kappa opioid receptor states | Nature Communications
Opioids: classification, uses, action and dependence - MedicalVerge
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Innovation – Cara Therapeutics
